Publikationen in Zusammenarbeit mit Forschern von Hospital de Móstoles (18)

2024

  1. Clustering COVID-19 ARDS patients through the first days of ICU admission. An analysis of the CIBERESUCICOVID Cohort

    Critical Care, Vol. 28, Núm. 1

2023

  1. Effects of intubation timing in patients with COVID-19 throughout the four waves of the pandemic: a matched analysis

    The European respiratory journal, Vol. 61, Núm. 3

  2. Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients

    Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 205-215

  3. Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients

    Intensive Care Medicine, Vol. 49, Núm. 8, pp. 934-945

2022

  1. Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study

    Intensive Care Medicine, Vol. 48, Núm. 7, pp. 850-864

  2. Methodology of a Large Multicenter Observational Study of Patients with COVID-19 in Spanish Intensive Care Units

    Archivos de Bronconeumologia, Vol. 58, pp. 22-31

  3. Prognostic implications of comorbidity patterns in critically ill COVID-19 patients: A multicenter, observational study

    The Lancet Regional Health - Europe, Vol. 18

2021

  1. Institutional factors associated with adherence to enhanced recovery protocols for colorectal surgery: Secondary analysis of a multicenter study

    Journal of Clinical Anesthesia, Vol. 74

2020

  1. Neuromuscular blockade management and postoperative outcomes in enhanced recovery colorectal surgery: Secondary analysis of POWER trial

    Minerva Anestesiologica, Vol. 87, Núm. 1, pp. 13-25

2019

  1. Clinical impact of circulating tumor RAS and BRAF mutation dynamics in patients with metastatic colorectal cancer treated with first-line chemotherapy plus anti–epidermal growth factor receptor therapy

    JCO Precision Oncology, Vol. 3

2018

  1. Coexpression of p-IGF-1R and MMP-7 Modulates Panitumumab and Cetuximab Efficacy in RAS Wild-Type Metastatic Colorectal Cancer Patients

    Neoplasia (United States), Vol. 20, Núm. 7, pp. 678-686

2017

  1. Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer

    British Journal of Cancer, Vol. 117, Núm. 12, pp. 1777-1786

2016

  1. Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome

    Critical Care, Vol. 20, Núm. 1

2014

  1. Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRAS metastatic colorectal cancer: Final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study)

    BMC Cancer, Vol. 14, Núm. 1

2011

  1. Community-acquired respiratory coinfection in critically III patients with pandemic 2009 influenza A(H1N1) virus

    Chest, Vol. 139, Núm. 3, pp. 555-562

  2. Impact of obesity in patients infected with 2009 influenza A(H1N1)

    Chest, Vol. 139, Núm. 2, pp. 382-386

  3. Severe pandemic (H1N1)v influenza A infection: Report on the first deaths in Spain

    Respirology, Vol. 16, Núm. 1, pp. 78-85

2005

  1. Randomised study of tegafur and oral leucovorin versus intravenous 5-fluorouracil and leucovorin in patients with advanced colorectal cancer

    European Journal of Cancer, Vol. 41, Núm. 15, pp. 2241-2249